← Leaderboards
Ann Marie Schmidt
Beckman Research Institute/City Of Hope
$32,042,569
Attributed
$40,047,273
Total exposure
28
Grants
20
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.9M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$78,416,499 · 31
By mechanism
P01$57,502,659 · 21
R01$15,022,824 · 8
R24$4,186,116 · 1
P50$1,704,900 · 1
Top collaborators
- Ravichandran Ramasamy26 shared
- Shi-Fang Yan6 shared
- Kamal Mohan Khanna2 shared
- Leonardo Trasande2 shared
- Lindsey Starr Trevino2 shared
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsDiabetes MellitusMacrophageCellsSignal TransductionReceptor For Advanced Glycation EndproductsAtherosclerosisLigandsInflammationMediatingTissuesRegulationLinkInflammatoryGenesPathway InteractionsPropertyCytoplasmic TailResponseFunctional DisorderDiabeticHuman SubjectLeadMolecular
Grant awards (143)
Early Life Exposure to Endocrine Disrupting Chemicals: Epigenomic and Transcriptomic Networks and RAGE in Liver Disease$767,661
R01 · FY2025 · ES
Effect of obesity and diabetes in regulating pulmonary and extra-pulmonary anti-viral immune responses$752,147
R01 · FY2025 · DK
RAGE, DIAPH1 and IRF7 and Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Disease$451,600
P01 · FY2025 · HL · contact PI
Mouse Breeding and Procedure Core$346,932
P01 · FY2025 · HL · contact PI
Effect of obesity and diabetes in regulating pulmonary and extra-pulmonary anti-viral immune responses$769,522
R01 · FY2024 · DK
Early Life Exposure to Endocrine Disrupting Chemicals: Epigenomic and Transcriptomic Networks and RAGE in Liver Disease$767,662
R01 · FY2024 · ES
Targeting RAGE/DIAPH1: Novel Therapeutic Strategy for Diabetic Complications$584,113
R01 · FY2024 · DK · contact PI
RAGE, DIAPH1 and IRF7 and Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Disease$499,778
P01 · FY2024 · HL · contact PI
Mouse Breeding and Procedure Core$373,142
P01 · FY2024 · HL · contact PI
Macrophages, Cell-Cell Communication, Ischemic Injury in Diabetes and the RAGE/DIAPH1 Signaling Axis$2,480,996
P01 · FY2023 · HL · contact PI
Targeting RAGE/DIAPH1: Novel Therapeutic Strategy for Diabetic Complications$615,294
R01 · FY2023 · DK · contact PI
Project 2: Diabetes, RAGE/DIAPH1 and Hind Limb Ischemia$576,182
P01 · FY2023 · HL · contact PI
RAGE, DIAPH1 and IRF7 and Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Disease$501,779
P01 · FY2023 · HL · contact PI
Mouse Breeding and Procedure Core$385,480
P01 · FY2023 · HL · contact PI
Admin Core$174,866
P01 · FY2023 · HL · contact PI
Macrophages, Cell-Cell Communication, Ischemic Injury in Diabetes and the RAGE/DIAPH1 Signaling Axis$2,480,272
P01 · FY2022 · HL · contact PI
Targeting RAGE/DIAPH1: Novel Therapeutic Strategy for Diabetic Complications$619,879
R01 · FY2022 · DK · contact PI
Project 2: Diabetes, RAGE/DIAPH1 and Hind Limb Ischemia$571,959
P01 · FY2022 · HL · contact PI
RAGE, DIAPH1 and IRF7 and Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Disease$501,779
P01 · FY2022 · HL · contact PI
Mouse Breeding and Procedure Core$385,480
P01 · FY2022 · HL · contact PI
Admin Core$174,865
P01 · FY2022 · HL · contact PI
Macrophages, Cell-Cell Communication, Ischemic Injury in Diabetes and the RAGE/DIAPH1 Signaling Axis$2,486,169
P01 · FY2021 · HL · contact PI
Targeting RAGE/DIAPH1: Novel Therapeutic Strategy for Diabetic Complications$636,596
R01 · FY2021 · DK · contact PI
Project 2: Diabetes, RAGE/DIAPH1 and Hind Limb Ischemia$574,907
P01 · FY2021 · HL · contact PI
Macrophage Trafficking, Inflammation & Metabolism in Adipose Tissue in High Fat Feeding: Role of AGE/RAGE/DIAPH1$438,405
P01 · FY2021 · HL · contact PI
Core C: Mouse Breeding & Microsurgery/Procedure Core$415,563
P01 · FY2021 · HL · contact PI
Admin Core$174,865
P01 · FY2021 · HL · contact PI
Macrophages, Cell-Cell Communication, Ischemic Injury in Diabetes and the RAGE/DIAPH1 Signaling Axis$2,494,008
P01 · FY2020 · HL · contact PI
Targeting RAGE/DIAPH1: Novel Therapeutic Strategy for Diabetic Complications$672,000
R01 · FY2020 · DK · contact PI
RAGE/mDia1, Macrophage Trafficking and Inflammation in Regression of Diabetic Atherosclerosis$622,217
R01 · FY2020 · HL
Project 2: Diabetes, RAGE/DIAPH1 and Hind Limb Ischemia$574,964
P01 · FY2020 · HL · contact PI
RAGE/mDia1, Macrophage Trafficking and Inflammation in High Fat Feeding$519,928
R01 · FY2020 · DK · contact PI
Macrophage Trafficking, Inflammation & Metabolism in Adipose Tissue in High Fat Feeding: Role of AGE/RAGE/DIAPH1$438,405
P01 · FY2020 · HL · contact PI
Core C: Mouse Breeding & Microsurgery/Procedure Core$433,208
P01 · FY2020 · HL · contact PI
Admin Core$174,865
P01 · FY2020 · HL · contact PI
Macrophages, Cell-Cell Communication, Ischemic Injury in Diabetes and the RAGE/DIAPH1 Signaling Axis$2,529,082
P01 · FY2019 · HL · contact PI
RAGE/mDia1, Macrophage Trafficking and Inflammation in Regression of Diabetic Atherosclerosis$622,217
R01 · FY2019 · HL
Project 2: Diabetes, RAGE/DIAPH1 and Hind Limb Ischemia$575,838
P01 · FY2019 · HL · contact PI
RAGE/mDia1, Macrophage Trafficking and Inflammation in High Fat Feeding$519,928
R01 · FY2019 · DK · contact PI
Core C: Mouse Breeding & Microsurgery/Procedure Core$433,081
P01 · FY2019 · HL · contact PI
Macrophage Trafficking, Inflammation & Metabolism in Adipose Tissue in High Fat Feeding: Role of AGE/RAGE/DIAPH1$408,409
P01 · FY2019 · HL · contact PI
Admin Core$174,865
P01 · FY2019 · HL · contact PI
Targeting RAGE-mDia1 in Diabetic Complications: Mechanisms and Therapeutics$849,287
R24 · FY2018 · DK · contact PI
RAGE/mDia1, Macrophage Trafficking and Inflammation in Regression of Diabetic Atherosclerosis$628,562
R01 · FY2018 · HL
RAGE/mDia1, Macrophage Trafficking and Inflammation in High Fat Feeding$519,928
R01 · FY2018 · DK · contact PI
Core C: Mouse Breeding & Microsurgery/Procedure Core$430,347
P01 · FY2018 · HL · contact PI
Macrophage Trafficking, Inflammation & Metabolism in Adipose Tissue in High Fat Feeding: Role of AGE/RAGE/DIAPH1$428,277
P01 · FY2018 · HL · contact PI
RAGE and Mechanisms of Vascular Dysfunction$1,496,524
P01 · FY2017 · HL · contact PI
Targeting RAGE-mDia1 in Diabetic Complications: Mechanisms and Therapeutics$849,652
R24 · FY2017 · DK · contact PI
RAGE/mDia1, Macrophage Trafficking and Inflammation in Regression of Diabetic Atherosclerosis$636,632
R01 · FY2017 · HL
RAGE/mDia1, Macrophage Trafficking and Inflammation in High Fat Feeding$526,420
R01 · FY2017 · DK · contact PI
Core C: Mouse Breeding & Microsurgery/Procedure Core$429,330
P01 · FY2017 · HL · contact PI
Macrophage Trafficking, Inflammation & Metabolism in Adipose Tissue in High Fat Feeding: Role of AGE/RAGE/DIAPH1$428,277
P01 · FY2017 · HL · contact PI
RAGE, Macrophages & HDL Biology$408,728
R01 · FY2017 · HL · contact PI
RAGE and mechanisms of accelerated atherosclerosis$273,228
P01 · FY2017 · HL · contact PI
Administrative, Biostatistics, and Data Management Core$169,452
P01 · FY2017 · HL · contact PI
RAGE and Mechanisms of Vascular Dysfunction$1,552,037
P01 · FY2016 · HL · contact PI
Targeting RAGE-mDia1 in Diabetic Complications: Mechanisms and Therapeutics$850,020
R24 · FY2016 · DK · contact PI
RAGE/mDia1, Macrophage Trafficking and Inflammation in High Fat Feeding$530,811
R01 · FY2016 · DK · contact PI
RAGE, Macrophages & HDL Biology$408,728
R01 · FY2016 · HL · contact PI
RAGE and mechanisms of accelerated atherosclerosis$283,746
P01 · FY2016 · HL · contact PI
Administrative, Biostatistics, and Data Management Core$174,476
P01 · FY2016 · HL · contact PI
RAGE and Mechanisms of Vascular Dysfunction$1,528,755
P01 · FY2015 · HL · contact PI
Targeting RAGE-mDia1 in Diabetic Complications: Mechanisms and Therapeutics$796,966
R24 · FY2015 · DK · contact PI
RAGE, Macrophages & HDL Biology$402,596
R01 · FY2015 · HL · contact PI
RAGE and mechanisms of accelerated atherosclerosis$279,121
P01 · FY2015 · HL · contact PI
Administrative, Biostatistics, and Data Management Core$173,104
P01 · FY2015 · HL · contact PI
Aging & Vulnerability to Ischemia: Pathways & Rescue$1,221,782
P01 · FY2014 · AG · contact PI
RAGE and Mechanisms of Vascular Dysfunction$1,190,892
P01 · FY2014 · HL · contact PI
Targeting RAGE-mDia1 in Diabetic Complications: Mechanisms and Therapeutics$840,191
R24 · FY2014 · DK · contact PI
RAGE, Macrophages & HDL Biology$437,910
R01 · FY2014 · HL · contact PI
RAGE and Mechanisms of Vascular Dysfunction$1,477,537
P01 · FY2013 · HL · contact PI
RAGE, Macrophages & HDL Biology$431,886
R01 · FY2013 · HL · contact PI
RAGE and mechanisms of accelerated atherosclerosis$269,767
P01 · FY2013 · HL · contact PI
Administrative, Biostatistics, and Data Management Core$167,305
P01 · FY2013 · HL · contact PI
Aging & Vulnerability to Ischemia: Pathways & Rescue$1,647,608
P01 · FY2012 · AG · contact PI
RAGE & ISCHEMIC STRESS IN AGING VASCULATURE$212,787
P01 · FY2012 · AG · contact PI
ADMINISTRATIVE, BIOSTATISTICS & DATA MANAGEMENT CORE$146,070
P01 · FY2012 · AG · contact PI
RAGE and Mechanisms of Vascular Dysfunction$3,370
P01 · FY2012 · HL · contact PI
Aging & Vulnerability to Ischemia: Pathways & Rescue$1,647,598
P01 · FY2011 · AG · contact PI
RAGE and Mechanisms of Vascular Dysfunction$1,502,539
P01 · FY2011 · HL · contact PI
RAGE and mechanisms of accelerated atherosclerosis$271,173
P01 · FY2011 · HL · contact PI
RAGE & ISCHEMIC STRESS IN AGING VASCULATURE$214,000
P01 · FY2011 · AG · contact PI
Administrative, Biostatistics, and Data Management Core$168,179
P01 · FY2011 · HL · contact PI
ADMINISTRATIVE, BIOSTATISTICS & DATA MANAGEMENT CORE$148,587
P01 · FY2011 · AG · contact PI
Aging & Vulnerability to Ischemia: Pathways & Rescue$1,585,460
P01 · FY2010 · AG · contact PI
RAGE AND NERVE INJURY, REGENERATION, DIABETES AND AGING$331,890
P01 · FY2010 · AG · contact PI
RAGE & ISCHEMIC STRESS IN AGING VASCULATURE$205,926
P01 · FY2010 · AG · contact PI
ADMINISTRATIVE, BIOSTATISTICS & DATA MANAGEMENT CORE$142,980
P01 · FY2010 · AG · contact PI
Aging & Vulnerability to Ischemia: Pathways & Rescue$1,554,840
P01 · FY2009 · AG · contact PI
RAGE AND NERVE INJURY, REGENERATION, DIABETES AND AGING$327,324
P01 · FY2009 · AG · contact PI
RAGE & ISCHEMIC STRESS IN AGING VASCULATURE$201,947
P01 · FY2009 · AG · contact PI
ADMINISTRATIVE, BIOSTATISTICS & DATA MANAGEMENT CORE$140,223
P01 · FY2009 · AG · contact PI
Aging & Vulnerability to Ischemia: Pathways & Rescue$1,509,542
P01 · FY2008 · AG · contact PI
RAGE and Mechanisms of Vascular Dysfunction$1,417,143
P01 · FY2008 · HL · contact PI
Ventricular Assist Devices: Bleeding, Thrombosis, & Novel Therapies$320,872
P50 · FY2008 · HL · contact PI
RAGE AND NERVE INJURY, REGENERATION, DIABETES AND AGING$309,468
P01 · FY2008 · AG · contact PI
RAGE and Mechanisms of Accelerated Atherosclerosis$257,318
P01 · FY2008 · HL · contact PI
RAGE & ISCHEMIC STRESS IN AGING VASCULATURE$196,066
P01 · FY2008 · AG · contact PI
Core--Administrative and Data Management and Analysis$140,244
P01 · FY2008 · HL · contact PI
ADMINISTRATIVE, BIOSTATISTICS & DATA MANAGEMENT CORE$136,137
P01 · FY2008 · AG · contact PI
RAGE and Mechanisms of Vascular Dysfunction$1,414,084
P01 · FY2007 · HL · contact PI
Ventricular Assist Devices: Bleeding, Thrombosis, & Novel Therapies$553,276
P50 · FY2007 · HL · contact PI
RAGE AND NERVE INJURY, REGENERATION, DIABETES AND AGING$307,072
P01 · FY2007 · AG · contact PI
RAGE and Mechanisms of Accelerated Atherosclerosis$255,038
P01 · FY2007 · HL · contact PI
Core--Administrative and Data Management and Analysis$138,895
P01 · FY2007 · HL · contact PI
RAGE and Mechanisms of Vascular Dysfunction$1,287,377
P01 · FY2006 · HL · contact PI
Ventricular Assist Devices: Bleeding/Thrombosis &Therapy$403,245
P50 · FY2006 · HL · contact PI
RAGE AND NERVE INJURY, REGENERATION, DIABETES AND AGING$307,533
P01 · FY2006 · AG · contact PI
RAGE and Mechanisms of Accelerated Atherosclerosis$147,883
P01 · FY2006 · HL · contact PI
RAGE and Mechanisms of Vascular Dysfunction$124,891
P01 · FY2006 · HL · contact PI
Core--Administrative and Data Management and Analysis$80,469
P01 · FY2006 · HL · contact PI
RAGE and Mechanisms of Vascular Dysfunction$1,286,322
P01 · FY2005 · HL
Ventricular Assist Devices: Bleeding/Thrombosis &Therapy$427,507
P50 · FY2005 · HL
RAGE and a Novel Tumor Axis$268,538
R01 · FY2005 · CA
RAGE and Mechanisms of Accelerated Atherosclerosis$144,042
P01 · FY2005 · HL
Core--Administrative and Data Management and Analysis$78,124
P01 · FY2005 · HL
RAGE and a Novel Tumor Axis$72,444
R01 · FY2005 · CA
RAGE and Mechanisms of Vascular Dysfunction$1,249,231
P01 · FY2004 · HL
RAGE and a Novel Tumor Axis$268,538
R01 · FY2004 · CA
RAGE and Mechanisms of Accelerated Atherosclerosis$139,980
P01 · FY2004 · HL
Core--Administrative and Data Management and Analysis$75,850
P01 · FY2004 · HL
RAGE and a Novel Tumor Axis$41,997
R01 · FY2004 · CA
RAGE AND MECHANISMS OF VASCULAR AND MONOCYTE DYSFUNCTION$1,201,167
P01 · FY2003 · HL
RAGE and a Novel Tumor Axis$268,538
R01 · FY2003 · CA
RAGE and a Novel Tumor Axis$268,538
R01 · FY2002 · CA
CORE--TRANSGENIC ANIMAL/RECOMBINANT PROTEIN$0
P01 · FY2002 · HL
VASCULAR AND MONOCYTE DYSFUNCTION IN ACCELERATED ATHEROSCLEROSIS$0
P01 · FY2002 · HL
CORE--TRANSGENIC MOUSE, AB, AND NEUROPATHOLOGIC LAB$0
P01 · FY2002 · AG
RAGE, NERVE INJURY, REGENERATION, AND AGING$0
P01 · FY2002 · AG
RAGE and a Novel Tumor Axis$268,538
R01 · FY2001 · CA
CORE--TRANSGENIC ANIMAL/RECOMBINANT PROTEIN$0
P01 · FY2001 · HL
RAGE, NERVE INJURY, REGENERATION, AND AGING$0
P01 · FY2001 · AG
CORE--TRANSGENIC MOUSE, AB, AND NEUROPATHOLOGIC LAB$0
P01 · FY2001 · AG
CORE--TRANSGENIC MOUSE, AB, AND NEUROPATHOLOGIC LAB$0
P01 · FY2001 · AG
RAGE, NERVE INJURY, REGENERATION, AND AGING$0
P01 · FY2001 · AG
VASCULAR AND MONOCYTE DYSFUNCTION IN ACCELERATED ATHEROSCLEROSIS$0
P01 · FY2001 · HL
VASCULAR AND MONOCYTE DYSFUNCTION IN ACCELERATED ATHEROSCLEROSIS$216,922
P01 · FY2000 · HL
CORE--TRANSGENIC ANIMAL/RECOMBINANT PROTEIN$216,922
P01 · FY2000 · HL
DIABETES ATHEROSCLEROSIS AND RAGE$206,737
P01 · FY2000 · HL
GLYCATION, RECEPTORS, CYTOKINES IN PERIODONTAL DISEASE$164,328
R01 · FY2000 · DE
RAGE, NERVE INJURY, REGENERATION, AND AGING$0
P01 · FY2000 · AG
CORE--TRANSGENIC MOUSE, AB, AND NEUROPATHOLOGIC LAB$0
P01 · FY2000 · AG